Premium
Effects of astaxanthin on sensory‐motor function in a compression model of spinal cord injury: Involvement of ERK and AKT signalling pathway
Author(s) -
Fakhri Sajad,
Dargahi Leila,
Abbaszadeh Fatemeh,
Jorjani Masoumeh
Publication year - 2019
Publication title -
european journal of pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.305
H-Index - 109
eISSN - 1532-2149
pISSN - 1090-3801
DOI - 10.1002/ejp.1342
Subject(s) - spinal cord injury , medicine , spinal cord , protein kinase b , anesthesia , signal transduction , biology , psychiatry , biochemistry
Abstract Background Spinal cord injury ( SCI ) causes continuous neurological deficits and major sensory‐motor impairments. There is no effective treatment to enhance sensory‐motor function following SCI . Thus, it is crucial to develop novel therapeutics for this particular patient population. Astaxanthin ( AST ) is a strong antioxidant, anti‐inflammatory and anti‐apoptotic agent. In the present study, it was tested in a severe compression SCI model with emphasis on sensory‐motor outcomes, signalling pathway, along with other complications. Methods A severe SCI was induced by compression of the rat thoracic spinal cord with an aneurysm clip and treatment with AST or the vehicle was carried out, 30 min after injury. Behavioural tests including open field, von Frey, hot plate and BBB were performed weekly to 28 days post‐injury. Rats were assigned to measure blood glucose, weight and auricle temperature. Western blot and histological analysis also were performed at the same time points. Results AST decreased mechanical and thermal pain and also improved motor function performance, reduced blood glucose and auricle temperature increases and attenuated weight loss in SCI rats. Western blot analysis showed decreased activation of ERK 1/2 and increased activation of AKT following AST treatment. The histology results revealed that AST considerably preserved myelinated white matter and the number of motor neurons following SCI . Conclusion Taken together, the beneficial effects of AST to improve sensory‐motor outcomes, attenuate pathological tissue damage and modulate ERK and AKT signalling pathways following SCI , suggest it as a strong therapeutic agent towards clinical applications. Significance Spinal cord injury ( SCI ) impairs sensory‐motor function and causes complications, which astaxanthin ( AST ) has the potential to be used as a treatment for. The present study investigates the effects of AST in a compression model of SCI with emphasis on sensory‐motor outcomes alongside other complications, histopathological damage and also related signalling pathways.